FDA Approves 2 Rapid, At-Home COVID Tests

A nurse swabs the nose of a patient as he administers a COVID-19 test. The Food and Drug Administration approved 2 brand-new fast, at-home COVID-19 tests for use by Americans Wednesday.

Jure Makovec/AFP by means of Getty Images

hide caption

toggle caption

Jure Makovec/AFP by means of Getty Images

A nurse swabs the nose of a patient as he administers a COVID-19 test. The Food and Drug Administration authorized 2 new quick, at-home COVID-19 tests for usage by Americans Wednesday.

Jure Makovec/AFP via Getty Images

More customers will soon be able to check themselves for COVID-19 from the convenience of their own home. On Wednesday, the Food and Drug Administration authorized 2 quick antigen home tests for use in the U.S.

Americans will soon be able to purchase Abbotts BinaxNOW and Quidel Quickvue tests at evaluates stores. The 2, newly-approved swab tests will be sold at a lower rate point.

Harvard epidemiologist Michael Mina informed NPR that if “we can stop all the break outs from growing, then boom, we can open up businesses and schools without danger due to the fact that the outbreaks … even if a case does come in, it blows over very quickly.”

” Screening screening, specifically with the over-the-counter tests licensed today, is a fundamental part of the countrys pandemic response– numerous schools, work environments, neighborhoods, and other entities are setting up screening programs to rapidly evaluate for COVID-19,” stated Dr. Jeffrey Shuren, director of the FDAs Center for Devices and Radiological Health.

Americans will soon be able to purchase AbbottBuy BinaxNOW and Quidel Quickvue tests at drug stores.

Professionals think the availability of at-home coronavirus tests might assist slow the continued spread of the virus, which is infectious even when people are asymptomatic.

More consumers will soon be able to check themselves for COVID-19 from the convenience of their own house. On Wednesday, the Food and Drug Administration authorized two quick antigen house tests for use in the U.S.

The BinaxNOW and Quickvue tests are anticipated to be sold in two-packs for around $15-20; Ellume costs $30.